NPA Seeks Clarified FDA Guidance On OTC Sunscreen Ingredient Review
This article was originally published in The Rose Sheet
Executive Summary
In response to FDA draft guidances mandated by the Sunscreen Innovation Act, the Natural Products Association pushes for clarification on GRASE data-submission requirements for combination active ingredients and urges the agency to make use of its Nonprescription Drug Advisory Committee beyond what the law requires to ensure that sunscreen ingredients receive attention and sponsors can stay compliant with SIA timetables.
You may also be interested in...
Sunscreen Industry Asks FDA For Flexibility Despite Guidances' Rigidity
FDA latest sunscreen guidances incorporate little industry input and are met with frustration and hope among industry stakeholders. The PASS Coalition and the Natural Products Association weigh in on future cooperation between FDA and industry under SIA.
Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024
Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.
Regulatory Acceptance Of Non-Animal Test Methods Holding Back Cosmetics Innovation
“Companies can innovate right now, and they have confidence in these tools, these [non-animal] approaches, and they feel they can put these products on the market safely,” said Erin Hill, CEO and president of the International Collaboration on Cosmetics Safety. “The holdup is that they can’t register these new products, because there’s a lack of confidence in the regulatory community.”